Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: R. M. Rosenthal who wrote (1052)	2/16/1998 10:27:00 PM
From: JanyBlueEyes	Respond to of 5736

CCSI INFORMATION PAGE ___________________________________________________________________________________________ This is a reference page for historical information on Chromatics Color Sciences International, Inc. Click on any underlined "link" below to view that information. Bookmark this page now for it will also serve to answer any questions that may come up. * -indicates items changed/added since the last update. ___________________________________________________________________________________________ CCSI'S PRODUCT & MARKET techstocks.com - Investor Fact Sheet - Research Magazine 10/97 LETTER TO STOCKHOLDERS 12/19/97 Message 3054670 CURRENT STATUS OF COMPANY * Message 3438092 - Comments - 2/15/98 Message 3034196 - Comments 12/23/97 Message 2873632 - Comments 12/4/97 Message 2862095 - Comments 12/2/97 techstocks.com - Comments 11/15/97 techstocks.com - Clips From the most recent 10Q 3 FOR 2 FORWARD STOCK SPLIT EFFECTIVE 2/17/98 * Message 3430552 - News - 3 For 2 Forward Stock Split, Preferred Stock Criteria Changes & Stock Option Plan Amendment Prominent Pediatricians On Medical Advisory Board Message 3033543 - News - 12/23/97 Message 3033819 - Info on Dr. Maisels Message 3033873 - Info on Dr. Holzman LEADING HEALTH CARE INDUSTRY CONSULTANT RETAINED Message 2848095 - News - 12/1/97 Message 2862287 - Comments 12/3/97 Message 2895457 - Frank's recent accomplishments Message 2907337 - News clips on Frank LETTER TO SHAREHOLDERS 5/1/97 techstocks.com APPROVAL FROM FDA techstocks.com - News Release 7/30/97 techstocks.com - Conference Call Transcript 8/12/97 techstocks.com - Conference Call Q & A 8/12/97 techstocks.com - Actual 510K Summary from FDA techstocks.com - Understanding the Summary SIZE OF MARKET techstocks.com - News Release 9/15/97 techstocks.com - Comments On News Release techstocks.com - Projections techstocks.com - TAM and SAM techstocks.com - Conference Call Transcript 9/17/97 PATENTS techstocks.com - Patent Protection techstocks.com - News 10/1/97 - Method and Apparatus for Detecting and Measuring Conditions Affecting Color" techstocks.com - Abstract from patent 10/1/97 techstocks.com - Links to previously awarded patents JAUNDICE & BILIRUBIN techstocks.com - Questions & Answers techstocks.com - Incidence of Jaundice in Asia techstocks.com - Jaundice & Bilirubin References TESTING NEWBORNS techstocks.com - Due Diligence on newborn blood testing. techstocks.com - Questions & Answers techstocks.com - Frequency of Testing for Jaundice techstocks.com - Easy to read article by a mother who went through testing her newborn. COMPETITION * techstocks.com - Different "Meters" techstocks.com - Studies done in Europe on other similar bilirubin measuring devices. techstocks.com - Conference Call Q & A 8/12/97 - Approximately the 5th question down. techstocks.com - Status of SpectRx 10/3/97 techstocks.com - Timeline of how long it took for CCSI to conduct clinicals and submit to FDA. COSMETICS / BEAUTY techstocks.com - Cosmetic / Beauty Press Releases up until 1994 techstocks.com - Status of Cosmetic / Beauty Area techstocks.com & techstocks.com - Handheld Model techstocks.com - CCSI's lawsuit with Avon - 1994 techstocks.com - Gordon Laboratory Deal 12/96 MOST RECENT QUARTERLY REPORT techstocks.com INSIDER TRADING insidertrader.com - November, 1997 insidertrader.com - October, 1997 insidertrader.com - September, 1997 insidertrader.com - July, 1997 techstocks.com - Insider Trading & Employment History Message 2800802 - Comments 11/23/97 SHORT INTEREST viwes.com - Short Interest From Nasdaq Last 4 Months CCSI STATISTICS * Message 3438252 - Estimation Of Float mgfs.com - Page 1 and Page 2 nasdaqtrader.com - Nasdaq quarterly reported volume and ranking for all Market Participants trading in CCSI stock RECENT EDGAR FILINGS edgar-partner.whowhere.com INSTITUTIONAL OWNERSHIP mgfs.com - up to date # Of Institutions and % Held (look under Current Statistics)

To: R. M. Rosenthal who wrote (1052)	2/16/1998 10:39:00 PM
From: David S.	Read Replies (4) \| Respond to of 5736

I have contacted the FDA regarding the status of CCSI's research and clinical trials in other "chromogenic" diseases. The FDA has a category of medical research that few people know about. It is the mental masturbation department. (That's fine, since Joclyn Elders wanted to teach all of us how to do that) Proposals by CCSI are being reviewed by the top analysts in this department. Stay tuned. Part II - The reason CCSI has taken so long to get a partner is due to Darby. The guy from Lehman was brought in because she finally realized that she had no clue on how to negotiate with health care companies. (or other firms in other industries). If you doubt, that, look at all the deals in the personal care/beauty/cosmetic industry that were tried and not renewed. Thanks to dear Frank and Lehman, a distribution deal with someone should happen, since the device works, and there is a market for it. In the US, they will be first to market, in the rest of the world, second as SPRX is already selling their device which does the same thing, but which is actually easier to use than CCSI's device. Regarding the hair care market, it would take a lot of convincing of American women that they need to have their current hair color measured prior to deciding on a new hair color. Regarding credibility, some people who like the stock do not tell lies, they just avoid the issues. Janybird is the world's finest cut and paste expert, and then claims all she did was cut and paste and makes no assertions on her own, other than Skippard is the expert, then Skippard creates earnings models that make one wonder if he can even balance a checkbook, let alone understand corporate finance. Here's a simple question that has yet to answered. Since SPRX already has a device on the market that does the noninvasive bilirubin testing, if these other chromogenic diseases existed, wouldn't bulls on that stock be discussing chromogenic diseases and the potential? Since they are not, ask why? Well, the reason is that they are not smoking the same stuff as people at CCSI (peanut shells). If the market for bilirubin testing is $15 gazillion dollars per week in Cincinatti, why would SPRX be more exited about the potential for the noninvasive glucose monitor for diabetes? A good magician knows how to divert the attention on the audience during the sleight of hand effect. Worth noting is that all the talk has been of the deal, the deal, reminding me of Tatoo's incessant parroting on the old TV show, "Fantasy Island" - the plane, the plane...Perhaps someone can answer the question why Healthdyne decided to become a marketing partner for SPRX - without the SPRX product even being approved yet in the US? They could have signed with CCSI. Why didn't they sign with CCSI? I know I shouldn't ask questions whose answers require more intelligence then that of day old sashimi, but occasionally it is rather fun.